coli consists of the normal intestinal colonization. Already at this stage the body is able to cope with these micro-organisms, accepting them as a part of the normal intestinal flora, but hindering them from invading the tissues. It is obvious, however, that from this early colonization onward the infant and then the child is carrying a reservoir of potentially pathogenic micro-organisms which are separated from the tissues only by the mucous membranes, supported by the host defence. This paper discusses Esch. coli infections in childhood with special reference to bacterial virulence factors and the immune defence mechanisms involved.
Normal colonization of the neonate Soon after birth the infant is colonized by bacteria, and among other species Esch. coli appear in the gut Gothefors et al., 1976) . Only in some neonates are these Esch. coli of the same serotype as the dominant strain in the mother's faecal flora. The origin of the remainder is not clear but hospital flora may be one source. In some cases it has been noted that a baby born in hospital first picks up an Esch. coli strain which only later is also found in the maternal stool (Gothefors, 1975; Gothefors et al., 1976) . Such colonization normally induces an antibody response against the Esch. coli at the serum and possibly local level, as shown by Lodinova, Jonja, and Wagner (1973) using an Esch. coli 083 for experimental colonization of infants.
What are the factors which normally prevent these potential pathogens from invading the neonate from the gut ? One poorly defined, but yet probably very important, mechanism is the 'colonization resistance' especially provided by the normal anaerobic flora of the gut (van der Waaij and Heidt, 1976 Probably the baby is also colonized early with these micro-organisms which are not well defined.
Another significant mechanism is the immune defence in mucous membranes, including those of the gut. Here a major component consists of locally produced secretory IgA (SIgA) antibodies. Such antibodies can prevent infection primarily by the simple function of binding micro-organisms, thereby hindering their contact with the mucous membranes and underlying tissues. During the first week of life the local antibody production in the form of SIgA may be present but sparse-SIgA consistently appears in the saliva at a few weeks of age (South, 1971) . At this age such antibodies are normally provided by the maternal milk which contains large amounts, SIgA making up almost half the protein content of the early colostrum (Hanson 1961; Hanson et al., 1971) . As the SIgA levels rapidly diminish in the colostrum within the first few days after birth, there is a simultaneous increase in the milk volume which compensates for this decrease in antibody concentration (Schubert and Grunberg, 1949; Carlsson et al., 1976b) (Fig.) , so that there is a high and rather constant output of SIgA antibodies throughout lactation.
It is striking that human milk contains SIgA antibodies against a multitude of 0 and K antigens of Esch. coli (Gindrat et al., 1972; Carlsson et al., 1976b; Hanson et al., 1975b Hanson et al., , 1976a )-surprising considering that the milk SIgA obviously is synthesized in the mammary gland and it is difficult to conceive how these enterobacterial antigens can induce local antibody production in the mammary gland. Recently it was possible to study this, however, on the basis of the observation that human milk contains large numbers of lymphoid cells (Smith and Goldman, 1968; Murillo and Goldman, 1970; Ahlstedt et al., 1975a (Goldblum et al., 1975) . There was no simultaneous serum antibody response in these women, which speaks against transport of antigens from the gut to the mammary gland and favours the assumption of a homing of antigen-triggered lymphoid cells from the Peyer's patches to the mammary gland. In this way the mother is immunized both locally in the gut and in the milk against the bacteria in her intestine (Bergstrom et al., 1972) and are generally assumed to originate from the gut flora. What makes them invade the intestinal mucosa and reach the blood stream and meninges causing such serious disease is yet unknown. It has been noted, however, that the capsular KI antigen is exceedingly common on Esch. coli causing neonatal meningitis, being found in about 80% of strains from infants with this disease (Robbins et al., 1974) .
With the Kl antigen presumably being an important virulence factor in these infections it is of some interest that colonization with Kl containing Esch. coli induces a serum antibody response only detectable in babies of over 6 months Glode et al., 1976) . On the other hand, most of the mothers have serum IgG and IgM anti-Kl antibodies, and about 80% of cord sera contain maternal IgG anti-KI, while absence of the IgG anti-Kl does not relate to increased risk for infection . Serum IgA anti-Kl are not so often found in the mothers though milk samples with very few exceptions contain secretory IgA anti-Kl. Deficiency in milk anti-Kl may increase the risk of the baby to attract neonatal Esch. coli infection, and Winberg and Wessner (1971) showed that a series of infants with neonatal sepsis/meningitis had consumed significantly smaller amounts of human milk than matched controls.
In support of the protective functions of human milk are also the lower number of Esch. coli in the stool of breast-fed compared to artificially-fed babies (Bullen and Willis, 1971; Michael, Ringeback, and Hottenstein, 1972) . This would diminish the infection dose in breast-fed infants and increase their chance of coping with the bacterial assault.
Besides the anti-KI, milk contains antibodies to several other Esch. coli K antigens and also many 0 antigens (Gindrat et al., 1972; Hanson et al., 1976a (McNeish et al., 1975) and invade the tissues more or less deeply like Shigella and Salmonella (Guerrant et al., 1975) . The other, where Esch. coli produce enterotoxins similar to Vibrio cholerae toxin in function (Guerrant et al., 1975; Holmgren and Svennerholm, 1976) .
We know little about the bacterial adhesion mechanism. It is possible that bacterial pili are important and that specific protein structures like the K88 present on Esch. coli enteropathogenic for the pig are present on Esch. coli with enteropathogenic activity in humans. If so, this is of importance, since antibodies to such structures crucial for pathogenicity may be efficiently protective and can perhaps be induced by vaccination.
Our knowledge of enterotoxigenic Esch. coli is scanty but the mechanism of their pathogenicity is most probably similar to that of V. cholerae with the toxin attaching to specific epithelial cell receptors (Holmgren and Svennerholm, 1976) . Secretory IgA antibodies against V. cholerae can prevent its adhesion to gut epithelium and its toxigenic effects in experimental models (Fubara and Freter, 1973; Holmgren and Svennerholm, 1976; Pierce and Sack, 1976) . This preventive effect is potentiated by the presence of normal gut flora (Schedlovsky and Freter, 1974) , probably exemplifying synergism between 'colonization resistance' and immunological factors (van der Waaij and Heidt, 1976) .
The lack of, or slow development of local immune defence in the neonate should increase the risk of diarrhoeal disease early in life. This is strikingly illustrated in developing countries where such diarrhoeal infections, especially accompanying undemutrition, often are life threatening. Mata and Urrutia (1971) and Mata and Wyatt (1971) have shown that the risk of such infections increases on weaning. This suggests that breastfeeding may provide protection. This is supported by the notion that infections with enteropathogenic Esch. coli do not occur in breast-fed infants (Crosse, 1966) and that epidemics with such bacteria can be controlled with human milk (Svirsky-Gross, 1958; Tassovatz and Kotsitch, 1961; Larguia et al., 1974) .
Recently we studied a small Esch. coli 0111 outbreak in Oslo (Andersen et al., 1976) ; 6 of the infants with the infection had severe diarrhoea and had not been breast fed. 2 breast-fed infants had Esch. coli 0111 in the stool but had only insignificant symptoms. There was no detectable anti-Oi1l in the milk from these mothers, however. This suggests firstly that even with a lack of specific antibodies to the Esch. coli the many other defence factors of the milk (Bullen and Willis, 1971; Bullen, Rogers, and Leigh, 1972; Hanson and Winberg, 1972; Gothefors, 1975) may help to alleviate the infection. Secondly, the infant may be colonized when the milk is antibody deficient. This may not happen when the baby is breast fed by a mother exposed more often to enteropathogenic Esch. coli. In accordance with this, the level of milk SIgA antibodies against the 0 antigens of enteropathogenic Esch. coli is much higher in the milk of Pakistani women than Swedish women, the latter supposedly rarely exposed to such Esch. coli (Ahistedt et al., 1976) . This was so in spite of the fact that the Pakistani women were severely undernourished, supporting the value of breast feeding also under such circumstances .
Since SIgA antibodies can help in preventing experimental cholera (Fubara and Freter, 1973; Holmgren and Svennerholm, 1976;  Pierce and Sack, 1976) , it is of interest that we recently found SIgA antibodies against Esch. coli enterotoxins in milk from Pakistani but not from Swedish mothers . This suggests that in areas where enterotoxin-producing Esch. coli occur, human milk may be important for protection against infantile diarrhoea caused by Esch. coli. Direct evidence for this is still lacking however, but it seems reasonable to promote breast feeding in paediatric practice as a preventive measure. In addition it may be possible to develop vaccination programmes for women resulting in improved protection also of their breast-fed babies.
Urinary tract infections (UTI). The most common Esch. coli infections in childhood are without doubt UTI. The neonatal infections may appear with insignificant or uncharacteristic symptoms like poor weight gain. During this period the UTI is often accompanied by bacteraemia and is assumed to have a haematogenous route from the gut to the urinary tract. The same bacterial strain is usually found in the gut as in the urine. After the neonatal period there are usually symptoms accompanying acute cystitis and pyelonephritis, but during the subsequent prevalent recurrences the infections more and more often cause none or only minor symptoms (Bergstrom et al., 1968) .
UTI during early life is related to a significant risk of developing renal parenchymal reduction and scarring (Hodson and Wilson, 1965) . Such changes have been seen in 4-50% of girls and 13 % of boys followed from their first-recognized infection (Winberg et al., 1974) . About one-quarter of these children developed lowered glomerular filtration capacity after an observation period of 8-15 years (Peterson et al., 1976) (Table I) . For details see Peterson et al., 1976 . *ml/min per 1 73 M2.
It is not clear how the symptomatic forms of UTI relate to the 'asymptomatic' cases of UTI often found on screening schoolgirls and others (Kunin, Deutscher, and Paquin, 1964) . Several ofthe patients with asymptomatic bacteriuria have a history of earlier UTI and in addition 10-26% of them have renal scarring suggesting earlier infections (Kunin et al., 1964; Savage et al., 1973; McLachlan et al., 1975; Lindberg et al., 1975b) .
Why do such infections occur and appear in these different forms ? Is the host defence abnormal in the urinary tract of some individuals or are other factors like reflux or residual urine mainly to blame ? The answers to these questions are not yet available but are of great importance because of the large number of patients with UTI and our deficient knowledge of how to handle them in many respects-especially how to prevent renal scarring.
We do know, however, that a serum antibody response is regularly detectable against the 0 antigen of the infecting Esch. coli (Winberg et al., 1963 (Ahlstedt, Holmgren, and Hanson, 1972; Ahlstedt et al., 1975b) . With the ammonium sulphate precipitation technique of Farr, increased antibody levels can actually be picked up in some cases of acute cystitis, possibly those with a pronounced tissue engagement (Ahlstedt, Jodal, and Hanson, 1975c) .
In contrast to the commonly encountered 0 antibody response, antibodies to the K antigens of the infecting bacteria are less consistently present. The Kl antigen, which is the most common capsular antigen among Esch. coli causing acute pyelonephritis in particular (39%) and UTI in general (28%; Kaijser, Hanson, and Robbins, 1976) , seems to induce nonresponsiveness in most patients with acute pyelonephritis (Kaijser, Jodal, and Hanson, 1973) . It is still unknown whether or not this has consequences for the clinical appearance and course of the disease. In addition to the serum antibody response there also seems to be a local antibody formation in the urinary tract against Esch. coli 0 and K antigens demonstrable in the urine especially as SIgA but also as IgG antibodies (Jodal et al., 1974; Hanson et al., 1975a) .
From experimental infections in animals it seems as if IgG as well as IgM antibodies against the 0 and especially the K antigen of the Esch. coli are protective (Kaijser, Holmgren, and Hanson, 1972; Kaijser and Olling, 1973) . This is true for haematogenous pyelonephritis and also, but at a lower level, for ascending pyelonephritis after parenteral and even intravesicular vaccination with killed bacteria (Kaijser and Larsson, 1976; Hanson et al., 1976b ). Finally we have recently noticed that Esch. coli strains isolated from the urine of patients with pyelonephritis adhere to epithelial cells from the normal human urinary tract much more efficiently than bacteria isolated from the urine of patients with asymptomatic bacteriuria (ABU) (Table II) . This adherence seems to be prevented in vitro by urine antibodies against the bacteria Svanborg Eden et al., 1976) .
There is only indirect evidence that the serum and urine antibodies against the infecting Esch. coli can affect the appearance and course of the disease in patients with UTI. Thus recurrences are in 800°caused by bacteria of a serotype different from that of the bacteria causing the preceding infection (Bergstrom et al., 1967) . Furthermore, continuous changes of surface characteristics seem to occur in Esch. coli isolated from the urine of longitudinally For details see Svanborg-Eden et al., 1976 followed untreated patients with ABU (Lindberg et al., 1975c; Hanson et al., 1976b (Lindberg et al., 1975d; Hanson et al., 1976b) . This may be another reason why there are so few or no symptoms in ABU. Thus, the adjustment of the micro-organisms in the urine to the host defence may have the clinically significant effect of a less harmful infection for the host. If this assumption holds true it has consequences for our evaluation of the needs for investigation, treatment, and follow-up of ABU patients.
Although 930% of patients with ABU can be successfully treated by a short course of nitrofurantoin, in 52% it will recur within 3 years and in 22%
it will recur repeatedly . In contrast, 300o of untreated ABU patients will rid themselves of the bacteria spontaneously, and during a 3-year follow-up there were no sign of effects on renal function or appearance on intravenous urography or micturition cystourethrography in patients still bacteriuric (Claesson and Lindberg, 1976 (Lindberg et al., 1975c; McLachlan et al., 1975) . We need, however, studies to make sure that we do not thereby miss patients who may develop renal parenchymal reduction, perhaps due to the presence of severe reflux, residual urine , or other mechanical factors. We need simple techniques to detect patients at risk for renal scarring (Winberg et al., 1974) and eventual lowered renal function (Peterson et al., 1976) . One method which holds promise for detecting patients with renal parenchymal involvement is the demonstration of increased levels of serum IgG autoantibodies to the Tamm-Horsfall protein normally present in renal tubules and urine (Hanson, Fasth, and Jodal, 1976c) . Another very simple but less specific pointer to renal involvement is the presence of increased levels of C-reactive protein in the blood (Jodal, Lindberg, and Lincoln, 1975; Jodal and Hanson, 1976 
